Pre-market Hot Trades in US Stocks
Banco Bradesco pre-market rose 13.04%. There are no significant news recently; trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. no_news
Apple pre-market rose 3.08%. Based on recent key news:
<ol>
<li>
On May 1, Apple reported second-quarter earnings that exceeded expectations, with revenue reaching $111.18 billion, driving the stock price up nearly 5% in after-hours trading. Apple also announced a $100 billion stock buyback plan, further boosting market confidence. Source: Bloomberg
</li>
<li>
On May 1, Apple projected third-quarter revenue growth of 14% to 17%, far exceeding analysts' expectations of 9.5%. This strong outlook alleviated market concerns about chip supply shortages. Source: Jinshi Data
</li>
<li>
On May 1, Apple stated in an analyst conference call that despite facing supply constraints, demand for MacBook Neo is strong, driving the stock price up. Source: Zhito Finance Technology industry chip supply tightness has widespread effects.
</li>
</ol>
Top Gainers in Pre-market US Stocks
22nd Century Group pre-market rose 67.25%. Based on recent key news:
<ol>
<li>
On April 29, 22nd Century Group shared its vision for 2026 regarding the growth of its VLN® products and leadership in tobacco harm reduction. This news enhanced market confidence in the company's future development, driving the stock price up.
</li>
<li>
On April 29, 22nd Century Group announced that it would release its first-quarter 2026 results on April 30. The market expects its revenue to be $4.61 million, with an EPS of -$1.20. Investors are optimistic about the upcoming financial report, further stimulating the stock price increase.
</li>
<li>
On April 30, 22nd Century Group released related content via GlobeNewswire, emphasizing its responsibility for information. This transparency increased investor trust, supporting the stock price rise. The US stock market has recently seen increased volatility, and risks need to be monitored.
</li>
</ol>
Cue Biopharma pre-market rose 54.21%. Based on recent key news:
<ol>
<li>
On April 30, Cue Biopharma announced a securities purchase agreement with certain qualified investors for a private placement of approximately $30 million. This move provides significant funding support for the company, driving the stock price up.
</li>
<li>
On April 30, Cue Biopharma appointed Shao-Lee Lin as the new CEO and President. Lin's extensive experience and leadership are seen by the market as a positive signal for the company's future development, further boosting the stock price.
</li>
<li>
On May 1, Cue Biopharma's PIPE financing is expected to be completed by May 4, meeting standard delivery requirements. This news enhances investor confidence in the company's financial stability, promoting the stock price rise. The biopharmaceutical industry has recently seen significant capital inflows
Akanda pre-market rose by 38.10%. Based on recent key news:
</li>
<li>
On May 1, the U.S. Department of Justice reclassified state-regulated cannabis as Schedule III, boosting investor confidence in cannabis stocks, leading to a significant rise in Akanda's stock price. The stock has increased by 300% this week, further driven up by its smaller float.
</li>
<li>
On April 30, Akanda's stock price was 361.5% above the 20-day simple moving average and 231.9% above the 100-day simple moving average, indicating strong short-term and medium-term rebound momentum. The Relative Strength Index (RSI) is at 89.71, indicating strong momentum.
</li>
<li>
On April 29, Akanda urged investors to vote in a timely manner to avoid further delays in company decisions. The company's positioning in the cannabis and digital infrastructure sectors has attracted market attention. The cannabis industry is significantly affected by policy changes
</li>
</ol>

BBDO

AAPL

Banco Bradesco pre-market up 13.04%; Apple pre-market up 3.08%; 22nd Century Group pre-market up 67.25%; Cue BioPharma pre-market up 54.21%; Akanda pre-market up 38.10%

- U.S. pre-market trading saw significant movements, with Bradshaw Bank up 13.04%, attributed to active trading, though specific reasons require further observation.  
- Apple experienced a 3.08% increase following strong Q2 performance exceeding expectations, a $100 billion stock buyback announcement, and a positive Q3 revenue forecast, alleviating supply concerns.  
- Cue Biopharma surged 54.21% due to a $30 million private placement agreement and the appointment of a new CEO, while Akanda rose 38.10% on the reclassification of cannabis by the DOJ, boosting market confidence in the sector.

Price Alert

Pre-market hot trades in US stocks: Banco Bradesco pre-market up 13.04%; Apple pre-market up 3.08%